Format

Send to

Choose Destination
J Clin Neurol. 2015 Apr;11(2):183-7. doi: 10.3988/jcn.2015.11.2.183. Epub 2014 Nov 11.

Molecular Genetic Diagnosis of a Bethlem Myopathy Family with an Autosomal-Dominant COL6A1 Mutation, as Evidenced by Exome Sequencing.

Author information

1
Department of Neurology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
2
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
3
Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
4
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
5
Department of Biological Science, Kongju National University, Gongju, Korea.
6
Department of Biological Science, Kongju National University, Gongju, Korea. kwchung@kongju.ac.kr.
7
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bochoi@skku.edu.

Abstract

BACKGROUND:

We describe herein the application of whole exome sequencing (WES) for the molecular genetic diagnosis of a large Korean family with dominantly inherited myopathy.

CASE REPORT:

The affected individuals presented with slowly progressive proximal weakness and ankle contracture. They were initially diagnosed with limb-girdle muscular dystrophy (LGMD) based on clinical and pathologic features. However, WES and subsequent capillary sequencing identified a pathogenic splicing-site mutation (c.1056+1G>A) in COL6A1, which was previously reported to be an underlying cause of Bethlem myopathy. After identification of the genetic cause of the disease, careful neurologic examination revealed subtle contracture of the interphalangeal joint in the affected members, which is a characteristic sign of Bethlem myopathy. Therefore, we revised the original diagnosis from LGMD to Bethlem myopathy.

CONCLUSIONS:

This is the first report of identification of COL6A1-mediated Bethlem myopathy in Korea, and indicates the utility of WES for the diagnosis of muscular dystrophy.

KEYWORDS:

Bethlem myopathy; collagen type VI alpha 1 (COL6A1); whole exome sequencing

Supplemental Content

Full text links

Icon for Korean Neurological Association Icon for PubMed Central
Loading ...
Support Center